The cannabinoid 2 receptor as a potential therapeutic target for sepsis

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 10, Issue 3, 2010, Pages 224-234

  Kasten, Kevin Richard ^a   Tschöp, Johannes ^b   Tschöp, Matthias Hans ^a   Caldwell, Charles Curtis ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

B cells; Inflammation; Macrophages; Neutophils; T cells

Indexed keywords

AMINO ACID; BENZOPYRAN DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; CD40 ANTIGEN; COMPLEMENTARY DNA; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYCLIC AMP; DELTA9(11) TETRAHYDROCANNABINOL; DEXANABINOL; ENDOCANNABINOID; GP1A; ICOSANOID; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NOLADIN ETHER; PROTEIN KINASE C; PYRAZOLE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRODHAMINE;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; BACTEREMIA; BLOOD LEVEL; CARDIOPULMONARY ARREST; CHEMOTAXIS; DEATH; DRUG TARGETING; EXON; HEART HEMODYNAMICS; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; KNOCKOUT MOUSE; LEUKEMIA CELL LINE; LEUKOCYTE; MOLECULAR CLONING; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR BINDING; REGULATORY MECHANISM; RESPIRATORY BURST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SIGNAL TRANSDUCTION; SPLEEN CELL; SURVIVAL;

EID: 78549277181     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153010791936874     Document Type: Article

References (102)

1. Matsuda, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C. and Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
2. Munro, S.; Thomas, K.L. and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
3. Shire, D.; Calandra, B.; Rinaldi-Carmona, M.; Oustric, D.; Pessegue, B.; Bonnin-Cabanne, O.; Le Fur, G.; Caput, D. and Ferrara, P. (1996) Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochim. Biophys. Acta, 1307, 132-136.
4. Okazaki, Y.; Furuno, M.; Kasukawa, T.; Adachi, J.; Bono, H.; Kondo, S.; Nikaido, I.; Osato, N.; Saito, R.; Suzuki, H.; Yamanaka, I.; Kiyosawa, H.; Yagi, K.; Tomaru, Y.; Hasegawa, Y.; Nogami, A.; Schonbach, C.; Gojobori, T.; Baldarelli, R.; Hill, D.P.; Bult, C.; Hume, D.A.; Quackenbush, J.; Schriml, L.M.; Kanapin, A.; Matsuda, H.; Batalov, S.; Beisel, K.W.; Blake, J.A.; Bradt, D.; Brusic, V.; Chothia, C.; Corbani, L.E.; Cousins, S.; Dalla, E.; Dragani, T.A.; Fletcher, C.F.; Forrest, A.; Frazer, K.S.; Gaasterland, T.; Gariboldi, M.; Gissi, C.; Godzik, A.; Gough, J.; Grimmond, S.; Gustincich, S.; Hirokawa, N.; Jackson, I.J.; Jarvis, E.D.; Kanai, A.; Kawaji, H.; Kawasawa, Y.; Kedzierski, R.M.; King, B.L.; Konagaya, A.; Kurochkin, I.V.; Lee, Y.; Lenhard, B.; Lyons, P.A.; Maglott, D.R.; Maltais, L.; Marchionni, L.; McKenzie, L.; Miki, H.; Nagashima, T.; Numata, K.; Okido, T.; Pavan, W.J.; Pertea, G.; Pesole, G.; Petrovsky, N.; Pillai, R.; Pontius, J.U.; Qi, D.; Ramachandran, S.; Ravasi, T.; Reed, J.C.; Reed, D.J.; Reid, J.; Ring, B.Z.; Ringwald, M.; Sandelin, A.; Schneider, C.; Semple, C.A.; Setou, M.; Shimada, K.; Sultana, R.; Takenaka, Y.; Taylor, M.S.; Teasdale, R.D.; Tomita, M.; Verardo, R.; Wagner, L.; Wahlestedt, C.; Wang, Y.; Watanabe, Y.; Wells, C.; Wilming, L.G.; Wynshaw-Boris, A.; Yanagisawa, M.; Yang, I.; Yang, L.; Yuan, Z.; Zavolan, M.; Zhu, Y.; Zimmer, A.; Carninci, P.; Hayatsu, N.; Hirozane-Kishikawa, T.; Konno, H.; Nakamura, M.; Sakazume, N.; Sato, K.; Shiraki, T.; Waki, K.; Kawai, J.; Aizawa, K.; Arakawa, T.; Fukuda, S.; Hara, A.; Hashizume, W.; Imotani, K.; Ishii, Y.; Itoh, M.; Kagawa, I.; Miyazaki, A.; Sakai, K.; Sasaki, D.; Shibata, K.; Shinagawa, A.; Yasunishi, A.; Yoshino, M.; Waterston, R.; Lander, E.S.; Rogers, J.; Birney, E. and Hayashizaki, Y. (2002) Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature, 420, 563-573.
5. Strausberg, R.L.; Feingold, E.A.; Grouse, L.H.; Derge, J.G.; Klausner, R.D.; Collins, F.S.; Wagner, L.; Shenmen, C.M.; Schuler, G.D.; Altschul, S.F.; Zeeberg, B.; Buetow, K.H.; Schaefer, C.F.; Bhat, N.K.; Hopkins, R.F.; Jordan, H.; Moore, T.; Max, S.I.; Wang, J.; Hsieh, F.; Diatchenko, L.; Marusina, K.; Farmer, A.A.; Rubin, G.M.; Hong, L.; Stapleton, M.; Soares, M.B.; Bonaldo, M.F.; Casavant, T.L.; Scheetz, T.E.; Brownstein, M.J.; Usdin, T.B.; Toshiyuki, S.; Carninci, P.; Prange, C.; Raha, S.S.; Loquellano, N.A.; Peters, G.J.; Abramson, R.D.; Mullahy, S.J.; Bosak, S.A.; McEwan, P.J.; McKernan, K.J.; Malek, J.A.; Gunaratne, P.H.; Richards, S.; Worley, K.C.; Hale, S.; Garcia, A.M.; Gay, L.J.; Hulyk, S.W.; Villalon, D.K.; Muzny, D.M.; Sodergren, E.J.; Lu, X.; Gibbs, R.A.; Fahey, J.; Helton, E.; Ketteman, M.; Madan, A.; Rodrigues, S.; Sanchez, A.; Whiting, M.; Young, A.C.; Shevchenko, Y.; Bouffard, G.G.; Blakesley, R.W.; Touchman, J.W.; Green, E.D.; Dickson, M.C.; Rodriguez, A.C.; Grimwood, J.; Schmutz, J.; Myers, R.M.; Butterfield, Y.S.; Krzywinski, M.I.; Skalska, U.; Smailus, D.E.; Schnerch, A.; Schein, J.E.; Jones, S.J. and Marra, M.A. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA, 99, 16899-16903.
6. Onaivi, E.S.; Ishiguro, H.; Gong, J.P.; Patel, S.; Perchuk, A.; Meozzi, P.A.; Myers, L.; Mora, Z.; Tagliaferro, P.; Gardner, E.; Brusco, A.; Akinshola, B.E.; Liu, Q.R.; Hope, B.; Iwasaki, S.; Arinami, T.; Teasenfitz, L. and Uhl, G.R. (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. N. Y. Acad. Sci., 1074, 514-536.
7. Sherwood, T.A.; Nong, L.; Agudelo, M.; Newton, C.; Widen, R. and Klein, T.W. (2009) Identification of transcription start sites and preferential expression of select CB2 transcripts in mouse and human B lymphocytes. J. Neuroimmune Pharmacol., 4, 476-488.
8. Condie, R.; Herring, A.; Koh, W.S.; Lee, M. and Kaminski, N.E. (1996) Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine Tcell line, EL4.IL-2. J. Biol. Chem., 271, 13175-13183.
9. Schatz, A.R.; Lee, M.; Condie, R.B.; Pulaski, J.T. and Kaminski, N.E. (1997) Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol., 142, 278-287.
10. Lee, S.F.; Newton, C.; Widen, R.; Friedman, H. and Klein, T.W. (2001) Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation. Eur. J. Pharmacol., 423, 235-241.
11. Olson, J.M.; Kennedy, S.J. and Cabral, G.A. (2003) Expression of the murine CB2 cannabinoid receptor using a recombinant Semliki Forest virus. Biochem. Pharmacol., 65, 1931-1942.
12. Redegeld, F.A.; Caldwell, C.C. and Sitkovsky, M.V. (1999) Ectoprotein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation? Trends Pharmacol. Sci., 20, 453-459.
13. Bouaboula, M.; Dussossoy, D. and Casellas, P. (1999) Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses. J. Biol. Chem., 274, 20397-20405.
14. Rinaldi-Carmona, M.; Barth, F.; Heaulme, M.; Shire, D.; Calandra, B.; Congy, C.; Martinez, S.; Maruani, J.; Neliat, G.; Caput, D.; et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
15. McCoy, K.L.; Gainey, D. and Cabral, G.A. (1995) delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther., 273, 1216-1223.
16. Buckley, N.E.; McCoy, K.L.; Mezey, E.; Bonner, T.; Zimmer, A.; Felder, C.C. and Glass, M. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol., 396, 141-149.
17. Tschop, J.; Kasten, K.R.; Nogueiras, R.; Goetzman, H.S.; Cave, C.M.; England, L.G.; Dattilo, J.; Lentsch, A.B.; Tschop, M.H. and Caldwell, C.C. (2009) The cannabinoid receptor 2 is critical for the host response to sepsis. J. Immunol., 183, 499-505.
18. Jeon, Y.J.; Yang, K.H.; Pulaski, J.T. and Kaminski, N.E. (1996) Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation. Mol. Pharmacol., 50, 334-341.
19. McCoy, K.L.; Matveyeva, M.; Carlisle, S.J. and Cabral, G.A. (1999) Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation. J. Pharmacol. Exp. Ther., 289, 1620-1625.
20. Liu, Q.R.; Pan, C.H.; Hishimoto, A.; Li, C.Y.; Xi, Z.X.; Llorente-Berzal, A.; Viveros, M.P.; Ishiguro, H.; Arinami, T.; Onaivi, E.S. and Uhl, G.R. (2009) Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav., 8, 519-530.
21. Das, S.K.; Paria, B.C.; Chakraborty, I. and Dey, S.K. (1995) Cannabinoid ligand-receptor signaling in the mouse uterus. Proc. Natl. Acad. Sci. USA, 92, 4332-4336.
22. Paria, B.C.; Das, S.K. and Dey, S.K. (1995) The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc. Natl. Acad. Sci. USA, 92, 9460-9464.
23. Ofek, O.; Karsak, M.; Leclerc, N.; Fogel, M.; Frenkel, B.; Wright, K.; Tam, J.; Attar-Namdar, M.; Kram, V.; Shohami, E.; Mechoulam, R.; Zimmer, A. and Bab, I. (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc. Natl. Acad. Sci. USA, 103, 696-701.
24. Galiegue, S.; Mary, S.; Marchand, J.; Dussossoy, D.; Carriere, D.; Carayon, P.; Bouaboula, M.; Shire, D.; Le Fur, G. and Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem., 232, 54-61.
25. Carayon, P.; Marchand, J.; Dussossoy, D.; Derocq, J.M.; Jbilo, O.; Bord, A.; Bouaboula, M.; Galiegue, S.; Mondiere, P.; Penarier, G.; Fur, G.L.; Defrance, T. and Casellas, P. (1998) Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood, 92, 3605-3615.
26. Ziring, D.; Wei, B.; Velazquez, P.; Schrage, M.; Buckley, N.E. and Braun, J. (2006) Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics, 58, 714-725.
27. McPartland, J.M.; Glass, M. and Pertwee, R.G. (2007) Metaanalysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br. J. Pharmacol., 152, 583-593.
28. Carlisle, S.J.; Marciano-Cabral, F.; Staab, A.; Ludwick, C. and Cabral, G.A. (2002) Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int. Immunopharmacol., 2, 69-82.
29. Mukhopadhyay, S.; Das, S.; Williams, E.A.; Moore, D.; Jones, J.D.; Zahm, D.S.; Ndengele, M.M.; Lechner, A.J. and Howlett, A.C. (2006) Lipopolysaccharide and cyclic AMP regulation of CB(2) cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages. J. Neuroimmunol., 181, 82-92.
30. Thomas, B.F.; Compton, D.R. and Martin, B.R. (1990) Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency. J. Pharmacol. Exp. Ther., 255, 624-630.
31. Derocq, J.M.; Bouaboula, M.; Marchand, J.; Rinaldi-Carmona, M.; Segui, M. and Casellas, P. (1998) The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Lett., 425, 419-425.
32. Jan, T.R.; Rao, G.K. and Kaminski, N.E. (2002) Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity. Mol. Pharmacol., 61, 446-454.
33. Oldham, W.M. and Hamm, H.E. (2008) Heterotrimeric G protein activation by G-protein-coupled receptors. Nat. Rev. Mol. Cell Biol., 9, 60-71.
34. Jorda, M.A.; Lowenberg, B. and Delwel, R. (2003) The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. Blood, 101, 1336-1343.
35. Simon, M.I.; Strathmann, M.P. and Gautam, N. (1991) Diversity of G proteins in signal transduction. Science, 252, 802-808.
36. Schatz, A.R.; Kessler, F.K. and Kaminski, N.E. (1992) Inhibition of adenylate cyclase by delta 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression. Life Sci., 51, PL25-30.
37. Kaminski, N.E.; Koh, W.S.; Yang, K.H.; Lee, M. and Kessler, F.K. (1994) Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol., 48, 1899-1908.
38. Kamenetsky, M.; Middelhaufe, S.; Bank, E.M.; Levin, L.R.; Buck, J. and Steegborn, C. (2006) Molecular details of cAMP generation in mammalian cells: a tale of two systems. J. Mol. Biol., 362, 623-639.
39. Benovic, J.L.; DeBlasi, A.; Stone, W.C.; Caron, M.G. and Lefkowitz, R.J. (1989) Beta-adrenergic receptor kinase: primary structure delineates a multigene family. Science, 246, 235-240.
40. Hausdorff, W.P.; Caron, M.G. and Lefkowitz, R.J. (1990) Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J., 4, 2881-2889.
41. Benovic, J.L.; Strasser, R.H.; Caron, M.G. and Lefkowitz, R.J. (1986) Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. USA, 83, 2797-2801.
42. Pei, G.; Samama, P.; Lohse, M.; Wang, M.; Codina, J. and Lefkowitz, R.J. (1994) A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc. Natl. Acad. Sci. USA, 91, 2699-2702.
43. MacEwan, D.J. and Milligan, G. (1996) Up-regulation of a constitutively active form of the beta2-adrenoceptor by sustained treatment with inverse agonists but not antagonists. FEBS Lett., 399, 108-112.
44. Zheng, D.; Bode, A.M.; Zhao, Q.; Cho, Y.Y.; Zhu, F.; Ma, W.Y. and Dong, Z. (2008) The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development. Cancer Res., 68, 3992-3998.
45. Bouaboula, M.; Desnoyer, N.; Carayon, P.; Combes, T. and Casellas, P. (1999) Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Mol. Pharmacol., 55, 473-480.
46. Correa, F.; Mestre, L.; Docagne, F. and Guaza, C. (2005) Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. Br. J. Pharmacol., 145, 441-448.
47. Alberich, J.M.; Rayman, N.; Tas, M.; Verbakel, S.E.; Battista, N.; van Lom, K.; Lowenberg, B.; Maccarrone, M. and Delwel, R. (2004) The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. Blood, 104, 526-534.
48. Franco, R.; Lluis, C.; Canela, E.I.; Mallol, J.; Agnati, L.; Casado, V.; Ciruela, F.; Ferre, S. and Fuxe, K. (2007) Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins. J. Neural. Transm., 114, 93-104.
49. Martin, A.B.; Fernandez-Espejo, E.; Ferrer, B.; Gorriti, M.A.; Bilbao, A.; Navarro, M.; Rodriguez de Fonseca, F. and Moratalla, R. (2008) Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptormediated motor behaviors. Neuropsychopharmacology, 33, 1667-1679.
50. Glass, M. and Felder, C.C. (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci., 17, 5327-5333.
51. Kearn, C.S.; Blake-Palmer, K.; Daniel, E.; Mackie, K. and Glass, M. (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol., 67, 1697-1704.
52. Devane, W.A.; Hanus, L.; Breuer, A.; Pertwee, R.G.; Stevenson, L.A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A. and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
53. Bosier, B.; Muccioli, G.G.; Hermans, E. and Lambert, D.M. (2010) Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities. Biochem. Pharmacol., 80, 1-12.
54. Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N.E.; Schatz, A.R.; Gopher, A.; Almog, S.; Martin, B.R.; Compton, D.R.; et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 83-90.
55. Sugiura, T.; Kondo, S.; Sukagawa, A.; Nakane, S.; Shinoda, A.; Itoh, K.; Yamashita, A. and Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 215, 89-97.
56. Basavarajappa, B.S. (2007) The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism. Mini Rev. Med. Chem., 7, 769-779.
57. Cravatt, B.F.; Giang, D.K.; Mayfield, S.P.; Boger, D.L.; Lerner, R.A. and Gilula, N.B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 83-87.
58. Cravatt, B.F.; Demarest, K.; Patricelli, M.P.; Bracey, M.H.; Giang, D.K.; Martin, B.R. and Lichtman, A.H. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA, 98, 9371-9376.
59. Howlett, A.C.; Barth, F.; Bonner, T.I.; Cabral, G.; Casellas, P.; Devane, W.A.; Felder, C.C.; Herkenham, M.; Mackie, K.; Martin, B.R.; Mechoulam, R. and Pertwee, R.G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.
60. [60] Murineddu, G.; Lazzari, P.; Ruiu, S.; Sanna, A.; Loriga, G.; Manca, I.; Falzoi, M.; Dessi, C.; Curzu, M.M.; Chelucci, G.; Pani, L. and Pinna, G.A. (2006) Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno [1,2-c]pyrazole-3-carboxamide. J. Med. Chem., 49, 7502-7512.
61. Rinaldi-Carmona, M.; Barth, F.; Millan, J.; Derocq, J.M.; Casellas, P.; Congy, C.; Oustric, D.; Sarran, M.; Bouaboula, M.; Calandra, B.; Portier, M.; Shire, D.; Breliere, J.C. and Le Fur, G.L. (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 284, 644-650.
62. Yao, B.B.; Mukherjee, S.; Fan, Y.; Garrison, T.R.; Daza, A.V.; Grayson, G.K.; Hooker, B.A.; Dart, M.J.; Sullivan, J.P. and Meyer, M.D. (2006) In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? Br. J. Pharmacol., 149, 145-154.
63. Mancini, I.; Brusa, R.; Quadrato, G.; Foglia, C.; Scandroglio, P.; Silverman, L.S.; Tulshian, D.; Reggiani, A. and Beltramo, M. (2009) Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242. Br. J. Pharmacol., 158, 382-391.
64. Paria, B.C.; Song, H.; Wang, X.; Schmid, P.C.; Krebsbach, R.J.; Schmid, H.H.; Bonner, T.I.; Zimmer, A. and Dey, S.K. (2001) Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J. Biol. Chem., 276, 20523-20528.
65. Buckley, N.E. (2008) The peripheral cannabinoid receptor knockout mice: an update. Br. J. Pharmacol., 153, 309-318.
66. Jarai, Z.; Wagner, J.A.; Varga, K.; Lake, K.D.; Compton, D.R.; Martin, B.R.; Zimmer, A.M.; Bonner, T.I.; Buckley, N.E.; Mezey, E.; Razdan, R.K.; Zimmer, A. and Kunos, G. (1999) Cannabinoidinduced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. USA, 96, 14136-14141.
67. Storr, M.A.; Keenan, C.M.; Zhang, H.; Patel, K.D.; Makriyannis, A. and Sharkey, K.A. (2009) Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm. Bowel Dis., 15, 1678-1685.
68. Ni, X.; Geller, E.B.; Eppihimer, M.J.; Eisenstein, T.K.; Adler, M.W. and Tuma, R.F. (2004) Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model. Mult. Scler., 10, 158-164.
69. Maresz, K.; Pryce, G.; Ponomarev, E.D.; Marsicano, G.; Croxford, J.L.; Shriver, L.P.; Ledent, C.; Cheng, X.; Carrier, E.J.; Mann, M.K.; Giovannoni, G.; Pertwee, R.G.; Yamamura, T.; Buckley, N.E.; Hillard, C.J.; Lutz, B.; Baker, D. and Dittel, B.N. (2007) Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat. Med., 13, 492-497.
70. Akhmetshina, A.; Dees, C.; Busch, N.; Beer, J.; Sarter, K.; Zwerina, J.; Zimmer, A.; Distler, O.; Schett, G. and Distler, J.H. (2009) The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis. Arthritis Rheum., 60, 1129-1136.
71. Csoka, B.; Nemeth, Z.H.; Mukhopadhyay, P.; Spolarics, Z.; Rajesh, M.; Federici, S.; Deitch, E.A.; Batkai, S.; Pacher, P. and Hasko, G. (2009) CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis. PLoS One, 4, e6409.
72. Gaffen, S.L. (2009) Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol., 9, 556-567.
73. Cencioni, M.T.; Chiurchiu, V.; Catanzaro, G.; Borsellino, G.; Bernardi, G.; Battistini, L. and Maccarrone, M. (2010) Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One, 5, e8688.
74. Sacerdote, P.; Massi, P.; Panerai, A.E. and Parolaro, D. (2000) In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J. Neuroimmunol., 109, 155-163.
75. Tannenbaum, C.S. and Hamilton, T.A. (1989) Lipopolysaccharideinduced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J. Immunol., 142, 1274-1280.
76. Khan, A.I.; Heit, B.; Andonegui, G.; Colarusso, P. and Kubes, P. (2005) Lipopolysaccharide: a p38 MAPK-dependent disrupter of neutrophil chemotaxis. Microcirculation, 12, 421-432.
77. Coxon, P.Y.; Rane, M.J.; Uriarte, S.; Powell, D.W.; Singh, S.; Butt, W.; Chen, Q. and McLeish, K.R. (2003) MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils. Cell Signal., 15, 993-1001.
78. Katakami, Y.; Nakao, Y.; Koizumi, T.; Katakami, N.; Ogawa, R. and Fujita, T. (1988) Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP. Immunology, 64, 719-724.
79. Han, K.H.; Lim, S.; Ryu, J.; Lee, C.W.; Kim, Y.; Kang, J.H.; Kang, S.S.; Ahn, Y.K.; Park, C.S. and Kim, J.J. (2009) CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc. Res., 84, 378-386.
80. Han, H.; Stessin, A.; Roberts, J.; Hess, K.; Gautam, N.; Kamenetsky, M.; Lou, O.; Hyde, E.; Nathan, N.; Muller, W.A.; Buck, J.; Levin, L.R. and Nathan, C. (2005) Calcium-sensing soluble adenylyl cyclase mediates TNF signal transduction in human neutrophils. J. Exp. Med., 202, 353-361.
81. Ottonello, L.; Morone, M.P.; Dapino, P. and Dallegri, F. (1995) Tumour necrosis factor alpha-induced oxidative burst in neutrophils adherent to fibronectin: effects of cyclic AMP-elevating agents. Br. J. Haematol., 91, 566-570.
82. Shiratsuchi, A.; Watanabe, I.; Yoshida, H. and Nakanishi, Y. (2008) Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis. Immunol. Cell Biol., 86, 179-184.
83. Hoesel, L.M.; Neff, T.A.; Neff, S.B.; Younger, J.G.; Olle, E.W.; Gao, H.; Pianko, M.J.; Bernacki, K.D.; Sarma, J.V. and Ward, P.A. (2005) Harmful and protective roles of neutrophils in sepsis. Shock, 24, 40-47.
84. Unsinger, J.; McGlynn, M.; Kasten, K.R.; Hoekzema, A.S.; Watanabe, E.; Muenzer, J.T.; McDonough, J.S.; Tschoep, J.; Ferguson, T.A.; McDunn, J.E.; Morre, M.; Hildeman, D.A.; Caldwell, C.C. and Hotchkiss, R.S. (2010) IL-7 Promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol., 184, 3768-3779.
85. Thiel, M.; Caldwell, C.C.; Kreth, S.; Kuboki, S.; Chen, P.; Smith, P.; Ohta, A.; Lentsch, A.B.; Lukashev, D. and Sitkovsky, M.V. (2007) Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One, 2, e853.
86. Martignoni, A.; Tschop, J.; Goetzman, H.S.; Choi, L.G.; Reid, M.D.; Johannigman, J.A.; Lentsch, A.B. and Caldwell, C.C. (2008) CD4-expressing cells are early mediators of the innate immune system during sepsis. Shock, 29, 591-597.
87. Tschop, J.; Martignoni, A.; Goetzman, H.S.; Choi, L.G.; Wang, Q.; Noel, J.G.; Ogle, C.K.; Pritts, T.A.; Johannigman, J.A.; Lentsch, A.B. and Caldwell, C.C. (2008) Gammadelta T cells mitigate the organ injury and mortality of sepsis. J. Leukoc. Biol., 83, 581-588.
88. [88] Kasten, K.R.; Tschoep, J.; Goetzman, H.S.; England, L.G.; Dattilo, J.; Cave, C.M.; Seitz, A.P.; Hildeman, D.A. and Caldwell, C.C. (2010) T cell activation differentially mediates the host response to sepsis. Shock [Epub ahead of print]
89. Klein, T.W.; Newton, C. and Friedman, H. (1998) Cannabinoid receptors and the cytokine network. Adv. Exp. Med. Biol., 437, 215-222.
90. Kaplan, B.L.; Rockwell, C.E. and Kaminski, N.E. (2003) Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. J. Pharmacol. Exp. Ther., 306, 1077-1085.
91. Newton, C.A.; Chou, P.J.; Perkins, I. and Klein, T.W. (2009) CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection. J. Neuroimmune Pharmacol., 4, 92-102.
92. Herring, A.C.; Koh, W.S. and Kaminski, N.E. (1998) Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid. Biochem. Pharmacol., 55, 1013-1023.
93. Chuchawankul, S.; Shima, M.; Buckley, N.E.; Hartmann, C.B. and McCoy, K.L. (2004) Role of cannabinoid receptors in inhibiting macrophage costimulatory activity. Int. Immunopharmacol., 4, 265-278.
94. Hotchkiss, R.S.; Chang, K.C.; Swanson, P.E.; Tinsley, K.W.; Hui, J.J.; Klender, P.; Xanthoudakis, S.; Roy, S.; Black, C.; Grimm, E.; Aspiotis, R.; Han, Y.; Nicholson, D.W. and Karl, I.E. (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol., 1, 496-501.
95. Hotchkiss, R.S.; Swanson, P.E.; Freeman, B.D.; Tinsley, K.W.; Cobb, J.P.; Matuschak, G.M.; Buchman, T.G. and Karl, I.E. (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med., 27, 1230-1251.
96. Hotchkiss, R.S.; Swanson, P.E.; Knudson, C.M.; Chang, K.C.; Cobb, J.P.; Osborne, D.F.; Zollner, K.M.; Buchman, T.G.; Korsmeyer, S.J. and Karl, I.E. (1999) Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol., 162, 4148-4156.
97. Hotchkiss, R.S.; Tinsley, K.W.; Swanson, P.E.; Chang, K.C.; Cobb, J.P.; Buchman, T.G.; Korsmeyer, S.J. and Karl, I.E. (1999) Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA, 96, 14541-14546.
98. Hotchkiss, R.S.; Tinsley, K.W.; Swanson, P.E.; Schmieg, R.E., Jr.; Hui, J.J.; Chang, K.C.; Osborne, D.F.; Freeman, B.D.; Cobb, J.P.; Buchman, T.G. and Karl, I.E. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol., 166, 6952-6963.
99. Wang, S.D.; Huang, K.J.; Lin, Y.S. and Lei, H.Y. (1994) Sepsisinduced apoptosis of the thymocytes in mice. J. Immunol., 152, 5014-5021.
100. Yanamadala, V.; Negoro, H. and Denker, B.M. (2009) Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes. Curr. Mol. Med., 9, 527-545.
101. McKallip, R.J.; Lombard, C.; Fisher, M.; Martin, B.R.; Ryu, S.; Grant, S.; Nagarkatti, P.S. and Nagarkatti, M. (2002) Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood, 100, 627-634.
102. McKallip, R.J.; Lombard, C.; Martin, B.R.; Nagarkatti, M. and Nagarkatti, P.S. (2002) Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. J. Pharmacol. Exp Ther., 302, 451-465.